null

SMILES COc1cc(\C=C\C(=O)CC(=O)\C=C\c2ccc(O)c(CO)c2)ccc1O

InChI Key InChIKey=UAVJPMNEDOIHEI-YPCIICBESA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 13 hits for monomerid = 191763   

TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
STC.UNM

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)copy SMILEScopy InChI
Affinity DataIC50: 8.20E+3nMAssay Description:The NF-kB activities of curcumin and analogs were determined by a cellular firefly luciferase assay. This assay utilized a commercially available cel...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2Q52NF9US Patent
TargetNeutrophil collagenase(Homo sapiens (Human))
The Research Foundation of State University of New York; Chem-Master International, Inc.

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)copy SMILEScopy InChI
Affinity DataIC50: 1.40E+4nMT: 2°CAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0M3VUS Patent
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
The Research Foundation of State University of New York; Chem-Master International, Inc.

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)copy SMILEScopy InChI
Affinity DataIC50: 2.90E+4nMT: 2°CAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0M3VUS Patent
Target72 kDa type IV collagenase(Homo sapiens (Human))
The Research Foundation of State University of New York; Chem-Master International, Inc.

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)copy SMILEScopy InChI
Affinity DataIC50: 8.50E+4nMT: 2°CAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0M3VUS Patent
TargetCollagenase 3(Homo sapiens (Human))
The Research Foundation of State University of New York; Chem-Master International, Inc.

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)copy SMILEScopy InChI
Affinity DataIC50: 1.10E+5nMT: 2°CAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0M3VUS Patent
TargetNeutrophil collagenase(Homo sapiens (Human))
The Research Foundation of State University of New York; Chem-Master International, Inc.

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)copy SMILEScopy InChI
Affinity DataIC50: 1.40E+4nMAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5X14US Patent
TargetCollagenase 3(Homo sapiens (Human))
The Research Foundation of State University of New York; Chem-Master International, Inc.

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)copy SMILEScopy InChI
Affinity DataIC50: 1.10E+5nMAssay Description:Table 10: The efficacy of MMP-2 inhibition was as follows: compound 6>compound 7>compound 8. Although compound 6 showed similar efficacy as curcumin ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2F47T2HUS Patent
Target72 kDa type IV collagenase(Homo sapiens (Human))
The Research Foundation of State University of New York; Chem-Master International, Inc.

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)copy SMILEScopy InChI
Affinity DataIC50: 8.50E+4nMAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5X14US Patent
TargetCollagenase 3(Homo sapiens (Human))
The Research Foundation of State University of New York; Chem-Master International, Inc.

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)copy SMILEScopy InChI
Affinity DataIC50: 1.10E+5nMAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5X14US Patent
TargetNeutrophil collagenase(Homo sapiens (Human))
The Research Foundation of State University of New York; Chem-Master International, Inc.

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)copy SMILEScopy InChI
Affinity DataIC50: 1.40E+4nMAssay Description:Table 1 shows the IC50 of curcumin, compound 1, and compound 2, compared to a standard Zn++ binding & MMPI (matrix metalloproteinase inhibitor), 1,10...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2F47T2HUS Patent
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
The Research Foundation of State University of New York; Chem-Master International, Inc.

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)copy SMILEScopy InChI
Affinity DataIC50: 2.90E+4nMAssay Description:Table 1 shows the IC50 of curcumin, compound 1, and compound 2, compared to a standard Zn++ binding & MMPI (matrix metalloproteinase inhibitor), 1,10...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2F47T2HUS Patent
Target72 kDa type IV collagenase(Homo sapiens (Human))
The Research Foundation of State University of New York; Chem-Master International, Inc.

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)copy SMILEScopy InChI
Affinity DataIC50: 8.50E+4nMAssay Description:Table 10: The efficacy of MMP-2 inhibition was as follows: compound 6>compound 7>compound 8. Although compound 6 showed similar efficacy as curcumin ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2F47T2HUS Patent
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
The Research Foundation of State University of New York; Chem-Master International, Inc.

US Patent
LigandPNGBDBM191763(US10669227, Compound Curcumin | US11608309, Compou...)copy SMILEScopy InChI
Affinity DataIC50: 2.90E+4nMAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5X14US Patent